⌘K

Login Start Free

Home/Filings/4/0000899243-21-031097

4//SEC Filing

Tak Paul Peter 4

Accession 0000899243-21-031097

CIK 0001841387other

View on SEC.gov Company Profile

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 8:09 PM ET

Size

9.3 KB

Accession

0000899243-21-031097

Insider Transaction Report

Form 4

Period: 2021-07-29

Candel Therapeutics, Inc.CADL

DirectorChief Executive Officer

Transactions

Purchase
Common Stock
2021-07-29$8.00/sh+25,000$200,000→ 25,000 total

Documents

2 files

Issuer

Candel Therapeutics, Inc.

CIK 0001841387

Entity typeother

Related Parties

1

filerCIK 0001873905

Filing Metadata

Form type: 4
Filed: Aug 1, 8:00 PM ET
Accepted: Aug 2, 8:09 PM ET
Size: 9.3 KB

View on SEC.gov